A biotechnology company developing gene-edited therapies for bacterial infections in the gut received a U.S. patent for viruses engineered as treatments. . . . → Read More: Patent Issued for Crispr-Edited Viruses in Microbiome
|
|||||
       
 |
A new company is acquiring a technology using genome-edited tadpoles that finds current drugs addressing precise genetic conditions underlying rare diseases. . . . → Read More: Start-Up Licenses Gene-Edited Drug Discovery Tech. 
A joint venture with business development and bio-manufacturing companies aims to build new cell and gene therapy businesses to advance treatments from Mayo Clinic labs. . . . → Read More: Venture to Build Cell, Gene Therapy Businesses  One comment - (Comments are closed)  Joint ventures/collaborations  biomedical, biotechnology, China, entrepreneurs, genomics, investment, licensing, life sciences, manufacturing, pharmaceuticals, stem cells 
A genetic technology for synthesizing cannabinoid compounds without cannabis cells was licensed to a company spun-off from the lab that developed the process. . . . → Read More: Cannabinoid Synthesis Process Licensed to Spin-Off Company Comments are closed Intellectual property, New products biomedical, biotechnology, chemistry, entrepreneurs, genomics, Israel, licensing, life sciences, pharmaceuticals, physical sciences, university 
Two companies agreed to license technologies from academic labs in the U.S. and U.K. for developing faster and more sensitive at-home tests for Covid-19 infections. . . . → Read More: Univ. Labs Ink Licensing Deals for Covid-19 Tests Comments are closed Intellectual property, New products biomedical, biotechnology, chemistry, Covid-19, entrepreneurs, genomics, licensing, life sciences, medical device, physical sciences, U.K., university 
A new biotechnology company demonstrated in lab mice its therapy for glioblastoma, an aggressive brain cancer, that overcomes limitations of current treatments. . . . → Read More: Biotech Start-Up Demonstrates Cancer Therapy, Raises $6.4M Comments are closed Finance, New products biomedical, biotechnology, cancer, chemistry, entrepreneurs, equity, genomics, investment, licensing, life sciences, pharmaceuticals, physical sciences, preclinical, university, venture capital 
Two companies working in women’s reproductive health are developing a new non-hormonal contraceptive that works in cervical mucous membranes. . . . → Read More: Women’s Health Companies Partner on New Contraceptive Comments are closed Intellectual property, Joint ventures/collaborations biomedical, biotechnology, challenge, entrepreneurs, Europe, licensing, life sciences, medical device, NIH, pharmaceuticals, preclinical 
Two biotechnology companies are advancing basic research findings connecting gut microbes with the brain to develop new therapies for neurological disorders. . . . → Read More: Biotechs Explore Gut-Brain Axis for Mental Health One comment - (Comments are closed) Joint ventures/collaborations, New products biomedical, biotechnology, entrepreneurs, investment, licensing, life sciences, pharmaceuticals, university 
An international health group is funding a new vaccine to cover a broad range of coronaviruses using exosomes, tiny natural bubbles for delivery to cells. . . . → Read More: CEPI Funds New Broad Coronavirus Vaccine One comment - (Comments are closed) Finance, New products biomedical, biotechnology, cancer, Covid-19, Europe, genomics, grant, licensing, life sciences, nanotechnology, preclinical, university 
A biotechnology company is licensing a gene-editing enzyme to Novartis to create treatments for inherited blood disorders such as sickle cell disease. . . . → Read More: Biotech in $1.5B Gene-Editing Tech License Deal Comments are closed Intellectual property, New products biomedical, biotechnology, Europe, genomics, licensing, life sciences, pharmaceuticals |
|
|||
|
Copyright © 2022 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
